Randomised trial evaluating chemotherapy alone or chemotherapy and a novel monoclonal antibody for canine T-cell lymphoma: A multicentre US study.
Margaret L MusserCraig A CliffordPhilip J BergmanLaura S TremlLydia C Cook McAnultyElizabeth A McNielChad M JohannesPublished in: Veterinary record open (2022)
To the best of the authors' knowledge, this is the first prospective study to document that treatment with L-CHOP chemotherapy, with or without AT-005, may result in a high ORR, but relatively brief PFS in dogs with clinical intermediate- and high-grade T-cell lymphoma.